Aesthetics device company Alma has unveiled a partnership with Prollenium to distribute Revanesse dermal filler and SoftFil cannulas in the UK.
From September 1, Alma will become the exclusive UK distributor of Revanesse and SoftFil, forming an Alma Injectables Division as the two companies’ teams unite. Alma will be providing comprehensive training and support through Harley Academy and Alma Studios training facilities.
Lior Dayan, CEO of Alma and Sisram, commented, “The strategic partnership with Prollenium and the introduction of Revanesse will allow us to bring a new era of innovation to the medical aesthetics specialty. Together, we are empowered to pioneer cutting-edge solutions by delivering high-end injectable products and proprietary technologies.”
CEO and founder of Prollenium Ario Khoshbin continued, “By partnering with Alma UK, we’re combining our strengths to offer clinics a powerful synergy of advanced injectables and cutting-edge energy-based technologies, ultimately enhancing patient outcomes and clinic success.”
